Neurological Deterioration in Acute Lacunar Infarctions
- 1 May 2001
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 32 (5), 1154-1161
- https://doi.org/10.1161/01.str.32.5.1154
Abstract
The mechanisms involved in the neurological deterioration of acute lacunar strokes are unknown. Although accumulating evidence suggests that glutamate release plays a role in the progression of territorial infarctions, it remains to be established whether excitotoxicity also participates in lacunar stroke progression. We investigated whether excitatory and inhibitory amino acid concentrations in blood predict subsequent progressive motor deficits in lacunar infarctions. We studied 113 consecutive patients with lacunar infarct, defined by clinical and computed tomography/magnetic resonance imaging criteria, within the first 24 hours after stroke onset. Neurological deterioration was defined as a decrease of >/=1 points in the motor items of the Canadian Stroke Scale in the first 48 hours after admission. Glutamate, glycine, and GABA were determined by high-performance liquid chromatography in plasma samples obtained on admission. Predictive values, sensitivity, specificity, and accuracy of specific glutamate and GABA concentrations and glutamatexglycine/GABA index for progression of lacunar stroke were calculated. Twenty-seven patients (23.9%) had neurological worsening. Plasma concentrations of glutamate (253+/-70 versus 123+/-73 micromol/L, mean+/-SD) were higher and those of GABA (140+/-63 versus 411+/-97 nmol/L) were lower in the progressing group than in the nonprogressing group (both P200 micromol/L and GABA levels 106 had a positive predictive value of 85%. These findings suggest that an imbalance between the glutamate and GABA concentrations may play a role in the pathophysiology of progressing lacunar infarctions.Keywords
This publication has 20 references indexed in Scilit:
- Progressive stroke caused by CT-verified small deep infarcts; relation with the size of the infarct and clinical outcomeActa Neurologica Scandinavica, 2009
- Neurotransmitters and pathophysiology of stroke: Evidence for the release of glutamate and other transmitters/mediators in animals and humansJournal Of Stroke & Cerebrovascular Diseases, 2000
- Serum Amino Acid Levels after Permanent Middle Cerebral Artery Occlusion in the RatCerebrovascular Diseases, 2000
- Clinical Features of Progressive Lacunar Infarction —Retrospective Analysis of Patients with Motor Syndromes—Neurologia medico-chirurgica, 1995
- Changes in Amino Acid Neurotransmitters and Cerebral Blood Flow in the Ischemic Penumbral Region following Middle Cerebral Artery Occlusion in the Rat: Correlation with HistopathologyJournal of Cerebral Blood Flow & Metabolism, 1993
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Formulas for threshold computationsComputers and Biomedical Research, 1991
- Excitotoxic index — a biochemical marker of selective vulnerabilityNeuroscience Letters, 1991
- Deteriorating ischemic strokeNeurology, 1990
- The Canadian Neurological ScaleNeurology, 1989